Authors: FINLEY PR SOMMER B CORBITT JL BRUNSON GH LUM BG

Citation: Pr. Finley et al., RISPERIDONE - CLINICAL OUTCOME PREDICTORS AND COST-EFFECTIVENESS IN ANATURALISTIC SETTING, Psychopharmacology bulletin, 33(3), 1997, pp. 524-524

Authors: FINLEY PR OBRIEN JG COLEMAN RW

Citation: Pr. Finley et al., LITHIUM AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS - EVALUATION OF A POTENTIAL INTERACTION, Journal of clinical psychopharmacology, 16(1), 1996, pp. 68-71

Authors: FINLEY PR BOGERT CL ALBERTS DS EINSPAHR J EARNEST DL BLACKWELL G GIRODIAS K

Citation: Pr. Finley et al., MEASUREMENT OF PROSTAGLANDIN E(2) IN RECTAL MUCOSA IN HUMAN-SUBJECTS - A METHOD STUDY, Cancer epidemiology, biomarkers & prevention, 4(3), 1995, pp. 239-244

Authors: FINLEY PR WARNER MD PEABODY CA

Citation: Pr. Finley et al., CLINICAL RELEVANCE OF DRUG-INTERACTIONS WITH LITHIUM, Clinical pharmacokinetics, 29(3), 1995, pp. 172-191

Authors: FINLEY PR

Citation: Pr. Finley, SELECTIVE SEROTONIN REUPTAKE INHIBITORS - PHARMACOLOGICAL PROFILES AND POTENTIAL THERAPEUTIC DISTINCTIONS, The Annals of pharmacotherapy, 28(12), 1994, pp. 1359-1369

Authors: FINLEY PR OBRIEN JG COLEMAN RW

Citation: Pr. Finley et al., LITHIUM (LI) AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR (ACEI) DRUG-INTERACTION, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 181-181